Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (598kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-520953
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.52095
Zusammenfassung
Introduction: Cormirnaty® was the first available vaccine in Europe that contains mRNA encoding the spike protein of SARS-CoV2. An enormous peptide commonality and thus molecular mimicry between SARS-CoV2 spike protein and human proteins could be shown. Molecular mimicry could be attributable to SARS-CoV2 associated illness. Objectives: So far saturation rate was not examined in patients ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags